- Senior Investigator, Metabolic Epidemiology Branch
Dr. Stolzenberg-Solomon received a B.S. in nutrition and dietetics at the University of California, Davis in 1984, followed by a dietetic internship and M.Ed. in health science (nutrition) education at Vanderbilt University Medical Center and George Peabody School of Education, respectively. After this training she worked as a registered dietitian for 10 years. In 1994 she completed a M.P.H. with concentrations in epidemiology and nutrition at the Johns Hopkins School of Hygiene and Public Health. Dr. Stolzenberg-Solomon joined the NCI in 1996 as a predoctoral fellow in the Cancer Prevention Studies Branch in the former Division of Cancer Prevention and Control and later the Center for Cancer Research, and subsequently earned a Ph.D. in epidemiology from the Johns Hopkins School of Hygiene and Public Health in 1999. As a Cancer Prevention Fellow, she continued postdoctoral research in the Division of Cancer Prevention and DCEG. She became an investigator in the Nutritional Epidemiology Branch in December 2002, and was awarded NIH scientific tenure and promoted to senior investigator in 2011.
Dr. Stolzenberg-Solomon has won several awards in recognition of her contributions to cancer research, including the 2008 NIH Merit Award for sustained and innovative work in elucidating nutritional, genetic, infectious, and other determinants of pancreatic cancer. She is an active mentor, working with graduate students, as well as postdoctoral fellows. She serves on the editorial board of the American Journal of Epidemiology and Cancer Epidemiology, Biomarkers, and Prevention. Dr. Stolzenberg-Solomon also holds a position as an adjunct associate professor at the Yale University School of Public Health and is a fellow of the American College of Epidemiology.
- (2020). Associations between reproductive factors and biliary tract cancers in women from the Biliary Tract Cancers Pooling Project. JOURNAL OF HEPATOLOGY. 73, 863-872.
- (2020). Associations between Genetically Predicted Blood Protein Biomarkers and Pancreatic Cancer Risk. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 29(7), 1501-1508.
- (2020). Genetic and Circulating Biomarker Data Improve Risk Prediction for Pancreatic Cancer in the General Population. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 29(5), 999-1008.
- (2020). Insulin Resistance in Healthy US Adults: Findings from the National Health and Nutrition Examination Survey (NHANES). CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 29(1), 157-168.
- (2019). Agnostic Pathway/Gene Set Analysis of Genome-Wide Association Data Identifies Associations for Pancreatic Cancer. JNCI-Journal of the National Cancer Institute. 111(6), 557-567.